These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 32016960)
41. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis. Yu Z; Wang Y; Wang B; Zhai J Cancer Biother Radiopharm; 2022 Nov; 37(9):792-801. PubMed ID: 32522016 [No Abstract] [Full Text] [Related]
42. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1. Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519 [TBL] [Abstract][Full Text] [Related]
43. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27. Jiang J; Xie C; Liu Y; Shi Q; Chen Y Biomed Pharmacother; 2019 Jan; 109():595-601. PubMed ID: 30399596 [TBL] [Abstract][Full Text] [Related]
44. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells. Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424 [TBL] [Abstract][Full Text] [Related]
46. LncRNA MEG3 Participates in Caerulein-Induced Inflammatory Injury in Human Pancreatic Cells via Regulating miR-195-5p/FGFR2 Axis and Inactivating NF-κB Pathway. Chen X; Song D Inflammation; 2021 Feb; 44(1):160-173. PubMed ID: 32856219 [TBL] [Abstract][Full Text] [Related]
48. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer. Zhang J; Guan W; Xu X; Wang F; Li X; Xu G Oncogene; 2021 Jul; 40(30):4906-4918. PubMed ID: 34163033 [TBL] [Abstract][Full Text] [Related]
49. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance. Yuan LL; Li L; Liu JN; Mei J; Lei CJ Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821 [TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis. Huang B; Wei M; Hong L Open Life Sci; 2021; 16(1):667-681. PubMed ID: 34250246 [TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer. Qu C; Dai C; Guo Y; Qin R; Liu J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301 [TBL] [Abstract][Full Text] [Related]
52. Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis. Gao Z; Wang Q; Ji M; Guo X; Li L; Su X J Transl Med; 2021 May; 19(1):229. PubMed ID: 34053467 [TBL] [Abstract][Full Text] [Related]
53. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p. Li J; Fan R; Xiao H Cancer Cell Int; 2021 Jan; 21(1):15. PubMed ID: 33407505 [TBL] [Abstract][Full Text] [Related]
54. [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells]. Jing S; Feng Y; He XL; Wang Y Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):56-63. PubMed ID: 36709121 [No Abstract] [Full Text] [Related]
55. LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p. Wang CB; Wang Y; Wang JJ; Guo XL Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1007-1022. PubMed ID: 32096180 [TBL] [Abstract][Full Text] [Related]
56. Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway. Huang G; Li L; Liang C; Yu F; Teng C; Pang Y; Wei T; Song J; Wang H; Liao X; Li Y; Yang J Pharmacol Res Perspect; 2021 Feb; 9(1):e00720. PubMed ID: 33565716 [TBL] [Abstract][Full Text] [Related]
57. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway. Li J; Zhang Z; Hu Y; Wei Q; Shao X Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988 [TBL] [Abstract][Full Text] [Related]
58. TRPM2-AS promotes paclitaxel resistance in prostate cancer by regulating FOXK1 via sponging miR-497-5p. Shi T; Li R; Duan P; Guan Y; Zhang D; Ding Z; Ruan X Drug Dev Res; 2022 Jun; 83(4):967-978. PubMed ID: 35238054 [TBL] [Abstract][Full Text] [Related]
59. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165 [TBL] [Abstract][Full Text] [Related]
60. Silencing of long noncoding RNA UCA1 inhibits colon cancer invasion, migration and epithelial-mesenchymal transition and tumour formation by upregulating miR-185-5p in vitro and in vivo. Cao C; Zhang J; Yang C; Xiang L; Liu W Cell Biochem Funct; 2020 Mar; 38(2):176-184. PubMed ID: 31989667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]